PODOFILOX (podofilox) by Design Pharmaceuticals is mechanism of action treatment of genital warts with podofilox results in necrosis of visible wart tissue. Approved for the treatment of perianal, mucous membrane warts (see ). First approved in 2002.
Drug data last refreshed 19h ago
Mechanism of Action Treatment of genital warts with podofilox results in necrosis of visible wart tissue. The exact mechanism of action is unknown.
Worked on PODOFILOX at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.